These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 25345808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.
    Ramakrishna V, Vasilakos JP, Tario JD, Berger MA, Wallace PK, Keler T.
    J Transl Med; 2007 Jan 25; 5():5. PubMed ID: 17254349
    [Abstract] [Full Text] [Related]

  • 3. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta.
    He LZ, Ramakrishna V, Connolly JE, Wang XT, Smith PA, Jones CL, Valkova-Valchanova M, Arunakumari A, Treml JF, Goldstein J, Wallace PK, Keler T, Endres MJ.
    Clin Cancer Res; 2004 Mar 15; 10(6):1920-7. PubMed ID: 15041707
    [Abstract] [Full Text] [Related]

  • 4. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.
    Morse MA, Chapman R, Powderly J, Blackwell K, Keler T, Green J, Riggs R, He LZ, Ramakrishna V, Vitale L, Zhao B, Butler SA, Hobeika A, Osada T, Davis T, Clay T, Lyerly HK.
    Clin Cancer Res; 2011 Jul 15; 17(14):4844-53. PubMed ID: 21632857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
    Wong JP, Christopher ME, Viswanathan S, Karpoff N, Dai X, Das D, Sun LQ, Wang M, Salazar AM.
    Vaccine; 2009 May 26; 27(25-26):3481-3. PubMed ID: 19200852
    [Abstract] [Full Text] [Related]

  • 11. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
    Zhu X, Nishimura F, Sasaki K, Fujita M, Dusak JE, Eguchi J, Fellows-Mayle W, Storkus WJ, Walker PR, Salazar AM, Okada H.
    J Transl Med; 2007 Feb 12; 5():10. PubMed ID: 17295916
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA.
    Blood; 1996 Jul 01; 88(1):202-10. PubMed ID: 8704175
    [Abstract] [Full Text] [Related]

  • 13. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.
    Ramakrishna V, Treml JF, Vitale L, Connolly JE, O'Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ.
    J Immunol; 2004 Mar 01; 172(5):2845-52. PubMed ID: 14978085
    [Abstract] [Full Text] [Related]

  • 14. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
    Ruane D, Do Y, Brane L, Garg A, Bozzacco L, Kraus T, Caskey M, Salazar A, Trumpheller C, Mehandru S.
    Mucosal Immunol; 2016 Sep 01; 9(5):1340-52. PubMed ID: 26732678
    [Abstract] [Full Text] [Related]

  • 15. A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
    Melssen MM, Petroni GR, Chianese-Bullock KA, Wages NA, Grosh WW, Varhegyi N, Smolkin ME, Smith KT, Galeassi NV, Deacon DH, Gaughan EM, Slingluff CL.
    J Immunother Cancer; 2019 Jun 27; 7(1):163. PubMed ID: 31248461
    [Abstract] [Full Text] [Related]

  • 16. The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii).
    Patchett AL, Tovar C, Corcoran LM, Lyons AB, Woods GM.
    Dev Comp Immunol; 2017 Nov 27; 76():352-360. PubMed ID: 28689773
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting.
    Thomann JS, Heurtault B, Weidner S, Brayé M, Beyrath J, Fournel S, Schuber F, Frisch B.
    Biomaterials; 2011 Jul 27; 32(20):4574-83. PubMed ID: 21474175
    [Abstract] [Full Text] [Related]

  • 18. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S.
    J Immunol; 2011 Jan 15; 186(2):1218-27. PubMed ID: 21149605
    [Abstract] [Full Text] [Related]

  • 19. Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
    Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, Philip S, Kerr N, Brennan A, Zheng Z, Ruehle K, Milliron T, Strome SE, Salazar AM, Levine BL, June CH.
    Clin Cancer Res; 2014 Mar 01; 20(5):1355-65. PubMed ID: 24520093
    [Abstract] [Full Text] [Related]

  • 20. Gene conjugation of molecular adjuvant C3d3 to hCGbeta increased the anti-hCGbeta Th2 and humoral immune response in DNA immunization.
    Wang XL, Zhao XR, Yu M, Yuan MM, Yao XY, Li DJ.
    J Gene Med; 2006 Apr 01; 8(4):498-505. PubMed ID: 16389614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.